Literature DB >> 1909350

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

B S Graham1, L A Bunton, P F Wright, D T Karzon.   

Abstract

The role of CD4+ and CD8+ T lymphocytes in terminating respiratory syncytial virus (RSV) replication, causing disease, and protecting from reinfection was investigated using a BALB/c mouse model in which CD4+ or CD8+ lymphocytes or both were depleted by injections of Mab directed against the respective mouse lymphocyte determinants. Kinetics of RSV replication, illness, and pathology were assessed after primary infection and rechallenge. Both CD4+ and CD8+ lymphocyte subsets were involved in terminating RSV replication after primary infection. When both T lymphocyte subsets were depleted RSV replication was markedly prolonged, yet no illness was evident, suggesting that host immune response rather than viral cytocidal effect was the primary determinant of disease in mice. Both CD4+ and CD8+ lymphocytes contributed to illness, although CD8+ lymphocytes appeared to play the dominant role in this particular system. Analysis of histological responses suggested that CD4+ lymphocytes were required for the appearance of peribronchovascular lymphocytic aggregates seen in normal mice after rechallenge, and that the presence of alveolar lymphocytes was correlated with illness. It is postulated that antibody is an illness-sparing mechanism for protecting mice from RSV infection, and that T lymphocytes are an important determinant of illness. Further delineation of RSV-induced immunopathogenesis in primary infection and reinfection will provide important information for the development of vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909350      PMCID: PMC295511          DOI: 10.1172/JCI115362

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody.

Authors:  M Rodriguez; S Sriram
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

2.  Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.

Authors:  S Cobbold; H Waldmann
Journal:  Transplantation       Date:  1986-05       Impact factor: 4.939

3.  Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells.

Authors:  B D Jamieson; L D Butler; R Ahmed
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Liver-derived cytotoxic T cells in hepatitis A virus infection.

Authors:  A Vallbracht; K Maier; Y D Stierhof; K H Wiedmann; B Flehmig; B Fleischer
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

5.  Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.

Authors:  Y Chiba; Y Higashidate; K Suga; K Honjo; H Tsutsumi; P L Ogra
Journal:  J Med Virol       Date:  1989-07       Impact factor: 2.327

6.  Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance.

Authors:  S P Cobbold; G Martin; S Qin; H Waldmann
Journal:  Nature       Date:  1986 Sep 11-17       Impact factor: 49.962

7.  Primary respiratory syncytial virus infection in mice.

Authors:  B S Graham; M D Perkins; P F Wright; D T Karzon
Journal:  J Med Virol       Date:  1988-10       Impact factor: 2.327

8.  Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

Authors:  D Isaacs; C R Bangham; A J McMichael
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321

9.  Cytotoxic T-cell response to respiratory syncytial virus in mice.

Authors:  C R Bangham; M J Cannon; D T Karzon; B A Askonas
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

10.  Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

Authors:  M J Cannon; P J Openshaw; B A Askonas
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  218 in total

1.  Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection.

Authors:  Natalie J Thornburg; Bryan Shepherd; James E Crowe
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.

Authors:  Na Zang; Xiaohong Xie; Yu Deng; Shengde Wu; Lijia Wang; Caijing Peng; Simin Li; Ke Ni; Yan Luo; Enmei Liu
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 4.  Pathogenesis of respiratory syncytial virus infection in the murine model.

Authors:  R Stokes Peebles; Barney S Graham
Journal:  Proc Am Thorac Soc       Date:  2005

5.  A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease.

Authors:  Takehiko Shibata; Manabu Ato
Journal:  Immunol Cell Biol       Date:  2017-07-19       Impact factor: 5.126

6.  Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Authors:  Y W Tang; B S Graham
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves.

Authors:  G Taylor; L H Thomas; S G Wyld; J Furze; P Sopp; C J Howard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 8.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

Authors:  M Connors; N A Giese; A B Kulkarni; C Y Firestone; H C Morse; B R Murphy
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Cell-mediated immune responses of lambs to challenge with bovine respiratory syncytial virus.

Authors:  A K Sharma; Z Woldehiwet
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.